4th Quarter - Report

AVENUE SOLUTIONS for MERCK & CO. INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Antibiotics/stewardship; S.1355/H.R.2940, PASTEUR Act of 2023; Issues related to the Vaccine Injury Compensation Program (VICP); Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization; Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation; Issues related to HPV vaccine and ACIP recommendations; Issues related to 340b; Issues related to the expiration/extension of Priority Review Vouchers (PRVs) for rare disease; H.R. 10545, American Relief Act, 2025

LobbyistCovered position, as disclosed
TRACY SPICER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2940 (118th), H.R. 10545 (118th), S. 1355 (118th)

Medicare/Medicaid MMM

Value of prescription drugs; Issues related to Medicare Parts B and D; Issues related to Medicare and Medicaid coverage and reimbursement

LobbyistCovered position, as disclosed
TRACY SPICER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.